Literature DB >> 16159081

Neuropathological correlates of reversible posterior leukoencephalopathy.

David Schiff1, Maria-Beatriz Lopes.   

Abstract

The pathogenesis and neuropathology of reversible posterior leukoencephalopathy (RPLE; a clinical and radiographical syndrome linked to malignant hypertension, eclampsia, immunosuppressive drugs, and chemotherapy) remain poorly understood. Autopsies on patients with hypertensive encephalopathy have demonstrated arteriolar fibrinoid necrosis with micro-infarcts and failed to show brain edema; nonetheless, magnetic resonance imagings (MRIs) of patients with RPLE generally show findings most consistent with vasogenic edema. This article reports a patient with RPLE in whom brain biopsy revealed edematous white matter with no evidence of vessel wall damage or infarction. This supports the concept that the imaging changes on MRI represent vasogenic edema and suggests that the changes observed on autopsy in malignant hypertension may be an epiphenomenon.

Entities:  

Mesh:

Year:  2005        PMID: 16159081     DOI: 10.1385/NCC:2:3:303

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  4 in total

1.  Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy.

Authors:  R B Schwartz; S K Feske; J F Polak; U DeGirolami; A Iaia; K M Beckner; S M Bravo; R A Klufas; R Y Chai; J T Repke
Journal:  Radiology       Date:  2000-11       Impact factor: 11.105

2.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

3.  Hypertensive encephalopathy: a clinicopathologic study of 20 cases.

Authors:  E M Chester; D P Agamanolis; B Q Banker; M Victor
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

4.  Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome?

Authors:  Kevin N Sheth; Gregory F Wu; Steven R Messé; Ronald L Wolf; Scott E Kasner
Journal:  Clin Neurol Neurosurg       Date:  2003-09       Impact factor: 1.876

  4 in total
  20 in total

Review 1.  Cerebral microinfarcts: the invisible lesions.

Authors:  Eric E Smith; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

Review 2.  Posterior reversible encephalopathy syndrome in intensive care medicine.

Authors:  Giuseppe Servillo; Francesca Bifulco; Edoardo De Robertis; Ornella Piazza; Pasquale Striano; Fabio Tortora; Salvatore Striano; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2006-11-21       Impact factor: 17.440

Review 3.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 4.  Posterior reversible encephalopathy syndrome during the peripartum period: report of four cases and review of the literature.

Authors:  Hasan Buyukaslan; Ugur Lok; Umut Gulacti; Ozgur Sogut; Halil Kaya; Tahir Gokdemir; Oner Yalin
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 5.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Authors:  Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

6.  Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Authors:  Samuel Singer; Christian Grommes; Anne S Reiner; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Oncologist       Date:  2015-06-01

7.  Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.

Authors:  R Dersch; O Stich; K Goller; S Meckel; F Dechent; S Doostkam; C Weiller; J Bardutzky
Journal:  J Neurol       Date:  2013-02-21       Impact factor: 4.849

8.  Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.

Authors:  J Merayo-Chalico; A Barrera-Vargas; G Juárez-Vega; J Alcocer-Varela; A Arauz; D Gómez-Martín
Journal:  Clin Exp Immunol       Date:  2018-01-16       Impact factor: 4.330

9.  Asymmetric posterior reversible encephalopathy syndrome complicating hemodynamic augmentation for subarachnoid hemorrhage-associated cerebral vasospasm.

Authors:  Barbara Voetsch; Nicholas Tarlov; Thanh N Nguyen; Christina DeFusco; Glenn D Barest; Alexander Norbash; Deborah M Green; Joseph D Burns
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

10.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.